With this background in mind, let’s take a look at the 12 best medical stocks to buy under $20.

Trump’s pick to lead the Health Department is targeting a multibillion-dollar ad market that’s one of the biggest spenders on ...

A Tennessee man admitted to creating and selling unapproved drugs for use in bodybuilding through his Kalispell business ...

AscellaHealth has unveiled its Specialty & Rare Pipeline Digest™, a comprehensive digital resource aimed at providing ...

The Indian air cargo market is at a pivotal moment, balancing growth potential with challenges. Projections estimate annual ...

A Tennessee man accused of creating and selling unapproved drugs for use in bodybuilding from his Kalispell business has ...

At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...

Executive interviews feature innovators and visionaries explaining the critical role that digital technologies play in ...

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

Small quantum computing stocks dived this week after Nvidia (NVDA) CEO Jensen Huang made clear to investors what they should have already known. Talking to analysts at the CES convention in Las Vegas ...

Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...